4
Changes in Ownership
Amylyx Pharmaceuticals, Inc. Filed Acc 0000899243-22-003157
10% owner bought 263,158 shares at $19.00 ($5,000,002)
- 10% owner acquired 10,415,650 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Morningside Venture Investments Ltd 10% owner | 2022-01-11 | Conversion | +10,415,650 | 10,415,650 | D | ||
| Morningside Venture Investments Ltd 10% owner | 2022-01-11 | Purchase | +263,158 | $19.00 | $5,000,002 | 10,678,808 | D |
| Derivatives | |||||||
| Morningside Venture Investments Ltd 10% owner | 2022-01-11 | Conversion · Series A Preferred Stock | −1,409,035 | 0 | D | ||
| Morningside Venture Investments Ltd 10% owner | 2022-01-11 | Conversion · Series B Preferred Stock | −6,410,964 | 0 | D | ||
| Morningside Venture Investments Ltd 10% owner | 2022-01-11 | Conversion · Series C-1 Preferred Stock | −974,107 | 0 | D | ||
| Morningside Venture Investments Ltd 10% owner | 2022-01-11 | Conversion · Series C-2 Preferred Stock | −1,621,544 | 0 | D | ||
| Open-market purchases · 263,158 sh · avg $19.00 · $5,000,002 | |||||||
Loading xslF345X03/doc4.xml…